April 2013

Monday, April 22, 2013

SIRIUS - A Documentary That Can End The Need For Fossil Fuels

The documentary went live to the world on April 22nd – You can watch it here!

Note: 100% of the net proceeds that Sirius Disclosure receives from the distribution of Sirius will go into building a free energy lab.

“Sirius” is a feature length documentary that follows Dr. Steven Greer - an Emergency Medicine doctor turned UFO/ New Energy researcher - as he struggles to disclose top secret information about classified energy & propulsion techniques.

Along the way, Dr. Steven Greer investigates new technology and sheds light on criminal suppression. He accumulates over 100 Government, Military, and Intelligence Community witnesses who testify on record about their first-hand experiences with UFOs and with the cover-up.

Sirius - A Documentary That Can End The Need For Fossil FuelsIn the course of his research Dr. Greer is asked to look at an amazing find: a humanoid specimen, 6 inches long from the Atacama Desert. Not until 2012 was he given permission to take bone samples and DNA from the specimen. At that same time a pre-eminent geneticist, hearing of this find, offered to do DNA testing.

He enlisted an MD from the same university,- world renowned for his work with skeletal anomalies, to view the xrays and CT scans.

Their expertise along with Dr. Greer’s expansive knowledge of the subject bring more questions than answers. Where did this “Atacama Humanoid” come from? Are there others like it? What does it say about the origin of the human species?

While on this odyssey, the audience gains a whole new perspective on technology, human evolution, and clandestine organizations who have manipulated and controlled the public for centuries.

“The future has already arrived. It's just not evenly distributed yet.” -William Gibson

Related Posts

Monday, April 8, 2013

Knowledge of Today Facebook Page has been unpublished without any explanation

UPDATE (Aprl 11 2013): It appears that our website being maliciously reported as 'phishy', triggered Facebook's automatic anti-spam algorithms to unpublish our Facebook page 2 days ago. However, Facebook hasn't officially replied anything to our appeals.

You can help us avoid such situations in the future, by submitting your rating to WOT Reputation ratings.

UPDATE (Aprl 9 2013): GOOD NEWS! The page has been restored but it's still limited. Our page's admins received (see screenshot below), a third notice: 'Your Page's posts are blocked from appearing in News Feed. This limit is temporary and expires Tuesday, April 16 at 2:10pm.'

The third notice was received approximately 5 hours after the second one.

UPDATE (Aprl 8 2013): Our page's admins were just notified (see screenshot below): 'Your Page has been unpublished and it cannot be published again. This limit is temporary and expires Tuesday, April 16 at 6:48am.'

The second notice was received approximately 8 hours after the initial one.

Knowledge of Today Facebook page has been unpublished today without any explanation.

You can support us by KINDLY asking Facebook to republish the page.

Here's the link: https://www.facebook.com/help/contact/357161520978587?rdrhc

Saturday, April 6, 2013

What Doctors Don't Know About the Drugs They Prescribe (TED Talk)

This TEDTalk is accompanied by an original blog post from the featured speaker. Watch the talk above, read the blog post and tell us your thoughts below.

Doctors need the results of clinical trials to make informed choices, with their patients, about which treatment to use. But the best currently available evidence estimates that half of all clinical trials, for the treatments we use today, have never been published. This problem is the same for industry-sponsored trials and independent academic studies, across all fields of medicine from surgery to oncology, and it represents an enormous hidden hole for everything we do. Doctors can't make informed decisions, when half the evidence is missing.

Most people react to this situation with incredulity, because it's so obviously absurd. How can medics, academics, and legislators have permitted such a huge problem to persist? The answer is simple. This territory has been policed -- and aggressively -- by the pharmaceutical industry. They have worked hard to shut down public discussion on the topic, for several decades, with great success.

They say, for example, that the problem is modest, and that critics have cherrypicked the evidence: but this is a lie. The best evidence comes from the most current review of all the literature, published in 2010. It estimates that half of all completed trials are left published, and that trials with negative results are about twice as likely to be buried.

Then they pretend that the problem is in the past, and that everything has been fixed. But in reality, none of these supposed fixes were subjected to any kind of routine public audit, and all have now been well-documented as failures. What's more, they all shared one simple loophole: they only demanded information about new trials, and this is hopeless. Anything that only gets us the results of studies completing after 2008 does nothing to fix medicine today, because more than 80% of all treatments prescribed this year came to the market more than ten years ago. We need the results of clinical trials from 2007, 2003, 1999, and 1993, to make informed decisions about the medicines we use today. This isn't about catching companies out for past misdemeanors, it's a simple practical matter of making medicine optimally safe and effective.

The arguments go on, with ever more red herrings: industry spokespeople pretend that information about trials -- such as Clinical Study Reports -- can't be released without breaching the confidentiality of individual patient participants. But in reality, the EU Ombudsman has already forced the European Medicines Agency (EMA) to release hundreds of these exact same documents. He stated clearly that the administrative burden of removing any individual patient information is minimal. Next, they claim the cost of sharing trial information is prohibitive: but both the EMA and GSK have committed to releasing all the Clinical Study Reports that they have, and the EMA has already shared millions of pages of documents, quite happily. Sometimes industry people even claim -- in hugely patronizing tones -- that it's better for only regulators to see trial results, behind closed doors, because the public would panic if exposed to dissenting views.

There's more. Sometimes they pretend that the academic journals are the bad guys, for rejecting papers with negative results, when the evidence shows this was barely ever an issue, and, in any case, there are now endless open access journals, specifically designed to accept negative results. Then there are the hole-pickers: people who pay lip service to the problem, with a brief claim that they are "on your side," then expend all their worldly effort trying to pour cold water on the problem, pretending that things aren't so bad after all.

Continue reading here.

Related Posts

This site's content is licensed under a Creative Commons Attribution 3.0 License. | Terms of Service